Fig. 3From: Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapyKaplan–Meier survival curves based on immunohistochemistry results. Five of seven biomarkers (EGFR, HER2, AURKA, BRCA1, PD-L1) are significantly associated with overall survival (OS) in HGSC and/or CCC patientsBack to article page